OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy
Daphne M. V. de Vries–Huizing, Else A. Aalbersberg, Michelle W. J. Versleijen, et al.
Cancer Imaging (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 45
Daphne M. V. de Vries–Huizing, Else A. Aalbersberg, Michelle W. J. Versleijen, et al.
Cancer Imaging (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 45
Showing 26-50 of 45 citing articles:
68Ga-DOTATATE PET/CT and MRI with Diffusion-Weighted Imaging (DWI) in Short- and Long-Term Assessment of Tumor Response of Neuroendocrine Liver Metastases (NELM) Following Transarterial Radioembolization (TARE)
Maria Ingenerf, Sophia Kiesl, Salma Karim, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4321-4321
Open Access | Times Cited: 9
Maria Ingenerf, Sophia Kiesl, Salma Karim, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4321-4321
Open Access | Times Cited: 9
Peptide receptor radionuclide therapy implementation and results in a predominantly gastrointestinal neuroendocrine tumor population
Alejandro Mejia, Elaina Vivian, Christiana Nwogu, et al.
Medicine (2022) Vol. 101, Iss. 9, pp. e28970-e28970
Open Access | Times Cited: 6
Alejandro Mejia, Elaina Vivian, Christiana Nwogu, et al.
Medicine (2022) Vol. 101, Iss. 9, pp. e28970-e28970
Open Access | Times Cited: 6
Neuroendocrine Tumor Therapy Response Assessment
Vetri Sudar Jayaprakasam, Lisa Bodei
PET Clinics (2023) Vol. 18, Iss. 2, pp. 267-286
Closed Access | Times Cited: 3
Vetri Sudar Jayaprakasam, Lisa Bodei
PET Clinics (2023) Vol. 18, Iss. 2, pp. 267-286
Closed Access | Times Cited: 3
Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy
Þorvarður R. Hálfdánarson, Nadine Mallak, Scott Paulson, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4836-4836
Open Access | Times Cited: 3
Þorvarður R. Hálfdánarson, Nadine Mallak, Scott Paulson, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4836-4836
Open Access | Times Cited: 3
Plasma Markers for Therapy Response Monitoring in Patients with Neuroendocrine Tumors Undergoing Peptide Receptor Radionuclide Therapy
Christoph Wetz, Tristan Ruhwedel, Imke Schatka, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5717-5717
Open Access | Times Cited: 3
Christoph Wetz, Tristan Ruhwedel, Imke Schatka, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5717-5717
Open Access | Times Cited: 3
Molecular and Anatomic Imaging of Neuroendocrine Tumors
László Szidonya, Eunkyung Park, Jennifer Kwak, et al.
Surgical Oncology Clinics of North America (2022) Vol. 31, Iss. 4, pp. 649-671
Closed Access | Times Cited: 5
László Szidonya, Eunkyung Park, Jennifer Kwak, et al.
Surgical Oncology Clinics of North America (2022) Vol. 31, Iss. 4, pp. 649-671
Closed Access | Times Cited: 5
Radiomics and Artificial Intelligence in Radiotheranostics: A Review of Applications for Radioligands Targeting SSTR and PSMA
Elmira Yazdani, Parham Geramifar, Najme Karamzade-Ziarati, et al.
(2023)
Open Access | Times Cited: 2
Elmira Yazdani, Parham Geramifar, Najme Karamzade-Ziarati, et al.
(2023)
Open Access | Times Cited: 2
A clinical score for neuroendocrine tumor patients under consideration for Lu-177-DOTATATE therapy
Satya Das, Liping Du, Aimee Schad, et al.
Endocrine Related Cancer (2021) Vol. 28, Iss. 3, pp. 203-212
Open Access | Times Cited: 5
Satya Das, Liping Du, Aimee Schad, et al.
Endocrine Related Cancer (2021) Vol. 28, Iss. 3, pp. 203-212
Open Access | Times Cited: 5
Are recist criteria adequate in assessing the response to therapy in metastatic NEN?
Marie‐Pierre Vullierme, Philippe Ruszniewski, Louis de Mestier
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 22, Iss. 3, pp. 637-645
Closed Access | Times Cited: 5
Marie‐Pierre Vullierme, Philippe Ruszniewski, Louis de Mestier
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 22, Iss. 3, pp. 637-645
Closed Access | Times Cited: 5
Neuroendocrine Tumors
Rebecca Wong, Ur Metser, Patrick Veit‐Haibach
PET Clinics (2021) Vol. 16, Iss. 3, pp. 353-364
Closed Access | Times Cited: 4
Rebecca Wong, Ur Metser, Patrick Veit‐Haibach
PET Clinics (2021) Vol. 16, Iss. 3, pp. 353-364
Closed Access | Times Cited: 4
Appendiceal Neuroendocrine Neoplasms: A Comprehensive Review
Renjith Padmanabhan Nair Sobha, Corey T. Jensen, Rebecca Waters, et al.
Journal of Computer Assisted Tomography (2023) Vol. 48, Iss. 4, pp. 545-562
Closed Access | Times Cited: 1
Renjith Padmanabhan Nair Sobha, Corey T. Jensen, Rebecca Waters, et al.
Journal of Computer Assisted Tomography (2023) Vol. 48, Iss. 4, pp. 545-562
Closed Access | Times Cited: 1
How to design a theranostic trial?
Dheeratama Siripongsatian, Quido G. de Lussanet, Frederik A. Verburg, et al.
Endocrine Oncology (2024) Vol. 4, Iss. 1
Open Access
Dheeratama Siripongsatian, Quido G. de Lussanet, Frederik A. Verburg, et al.
Endocrine Oncology (2024) Vol. 4, Iss. 1
Open Access
Cylindrical TGR as early radiological predictor of RLT progression in GEPNETs: a proof of concept
Federica Scalorbi, Enrico Garanzini, Giuseppina Calareso, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Federica Scalorbi, Enrico Garanzini, Giuseppina Calareso, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
The Role of Ga-68-PSMA PET/CT in the Initial Staging of Prostate Cancer – A Single Center 4 Year Experience
João Pedroso Lima, João Carvalho, Vasco Quaresma, et al.
Research and Reports in Urology (2021) Vol. Volume 13, pp. 479-485
Open Access | Times Cited: 3
João Pedroso Lima, João Carvalho, Vasco Quaresma, et al.
Research and Reports in Urology (2021) Vol. Volume 13, pp. 479-485
Open Access | Times Cited: 3
Theranostics in oncology: What radiologists want to know
Justin Ferdinandus, Wolfgang P. Fendler, Joshua James Morigi, et al.
European Journal of Radiology (2021) Vol. 142, pp. 109875-109875
Closed Access | Times Cited: 3
Justin Ferdinandus, Wolfgang P. Fendler, Joshua James Morigi, et al.
European Journal of Radiology (2021) Vol. 142, pp. 109875-109875
Closed Access | Times Cited: 3
Peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE
S. Prado-Wohlwend, J.C. Bernal-Vergara, A. Utrera-Costero, et al.
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) (2021) Vol. 41, Iss. 1, pp. 55-65
Closed Access | Times Cited: 3
S. Prado-Wohlwend, J.C. Bernal-Vergara, A. Utrera-Costero, et al.
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) (2021) Vol. 41, Iss. 1, pp. 55-65
Closed Access | Times Cited: 3
Optimizing surveillance strategies in gastroenteropancreatic neuroendocrine tumours
Mark Jean Cornel van Treijen
(2022)
Open Access
Mark Jean Cornel van Treijen
(2022)
Open Access
Ga-68 DOTATATE PET/CT in the Evaluation of Therapy Response in Neuroendocrine Tumors
Ömer Küçük, Mine Araz
Nuclear Medicine Seminars (2021) Vol. 7, Iss. 2, pp. 236-240
Open Access
Ömer Küçük, Mine Araz
Nuclear Medicine Seminars (2021) Vol. 7, Iss. 2, pp. 236-240
Open Access
Terapia con péptidos radiomarcados con [177Lu]Lu-DOTA-TATE
S. Prado-Wohlwend, J.C. Bernal-Vergara, A. Utrera-Costero, et al.
Revista Española de Medicina Nuclear e Imagen Molecular (2021) Vol. 41, Iss. 1, pp. 55-65
Closed Access
S. Prado-Wohlwend, J.C. Bernal-Vergara, A. Utrera-Costero, et al.
Revista Española de Medicina Nuclear e Imagen Molecular (2021) Vol. 41, Iss. 1, pp. 55-65
Closed Access
